Session Onekeyboard_arrow_right
Search keyboard_arrow_right
keyboard_arrow_left Hide
Session One
search
Session One
search
Reviewing the organisation of the US Food and Drug Administration (FDA) and how this may impact future regulation
Examining drug development regulations in the US and implications for the industry
Evaluation of review options
Analysing the Investigational New Drug Application (IND) and defining the regulatory requirements
Maintaining active INDs successfully
Identifying recent changes and other IND/ NDA topics